[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![doepke_michel Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1350720698591936515.png) Michel Doepke [@doepke_michel](/creator/twitter/doepke_michel) on x 4936 followers
Created: 2025-07-14 13:40:59 UTC

$NBIX Presents One-Year Data Showing Sustained Efficacy of CRENESSITY (crinecerfont) in Adult Patients, at ENDO 2025. Should be supportive for a strong launch. Q2 earnings on Wednesday, July XX.


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1944753998977802410/c:line.svg)

**Related Topics**
[stocks](/topic/stocks)
[oneyear](/topic/oneyear)
[$nbix](/topic/$nbix)
[neurocrine biosciences inc](/topic/neurocrine-biosciences-inc)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/doepke_michel/status/1944753998977802410)